0.00
Blueprint Medicines Corp Aktie (BPMC) Neueste Nachrichten
Blueprint Medicines director Jeffrey Albers sells shares for $1.66 million - MSN
Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting - Yahoo Finance
Can Blueprint Medicines Corporation (2L9) stock double in coming yearsJuly 2025 Volume & Low Drawdown Investment Ideas - Newser
Is Blueprint Medicines Corporation (2L9) stock ideal for retirement investorsWeekly Loss Report & Weekly Sector Rotation Insights - Newser
Why Blueprint Medicines Corporation stock remains on watchlistsJuly 2025 Momentum & Free High Return Stock Watch Alerts - Newser
Is Blueprint Medicines Corporation (2L9) stock a good hedge against inflation2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
Will Blueprint Medicines Corporation (2L9) stock see valuation expansionBull Run & Technical Confirmation Trade Alerts - Newser
Will Blueprint Medicines Corporation stock benefit from automationVolume Spike & Technical Buy Zone Confirmations - moha.gov.vn
How Blueprint Medicines Corporation (2L9) stock compares with tech leadersJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - BỘ NỘI VỤ
Blueprint Medicines patents new CDK4 degradation inducers - BioWorld MedTech
CG Oncology (NASDAQ: CGON) names Rossi to board amid BLA initiation - Stock Titan
What makes Blueprint Medicines Corporation stock attractive to growth funds2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
What dividend safety rating applies to Blueprint Medicines Corporation (2L9) stock2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com
Why Blueprint Medicines Corporation (2L9) stock remains stable2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
How strong is Blueprint Medicines Corporation (2L9) stock earnings growth2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Can momentum traders help lift Blueprint Medicines CorporationEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
What the charts say about Blueprint Medicines Corporation todayJuly 2025 Action & Target Return Focused Picks - newser.com
How Blueprint Medicines Corporation stock reacts to bond yieldsJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - newser.com
Will Blueprint Medicines Corporation stock continue upward momentumJuly 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com
Is Blueprint Medicines Corporation stock a good choice for value investors2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - Fundação Cultural do Pará
What catalysts could drive Blueprint Medicines Corporation stock higherMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
How geopolitical tensions affect Blueprint Medicines Corporation stockFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Sanofi to buy Blueprint Medicines for $9.1B - MSN
Blueprint Medicines CorporationCommon Stock (NQ: BPMC - Markets Financial Content
Is Blueprint Medicines Corporation (2L9) stock a contrarian opportunityEarnings Overview Report & Weekly Breakout Watchlists - newser.com
Will Blueprint Medicines Corporation stock remain a Wall Street favorite - newser.com
Blueprint Medicines Corporation stock volume spike explainedExit Point & Stepwise Trade Signal Guides - newser.com
How Blueprint Medicines Corporation stock benefits from global expansion2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
Will Blueprint Medicines Corporation stock split again soonWeekly Volume Report & Real-Time Volume Analysis Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):